HPV Vaccination Rates Among Males Rise in Singapore as Awareness of Cancer Prevention Grows
Singapore is experiencing a notable increase in HPV vaccination uptake among males, driven by growing public awareness of the vaccine’s role in preventing multiple cancers. While historically targeted primarily at females, the vaccine’s expanded benefits—including protection against oropharyngeal, anal, and penile cancers—are prompting more men to seek immunization. Government subsidies and targeted health campaigns are further accelerating this shift.
Why the Shift Toward Male HPV Vaccination?
The human papillomavirus (HPV) is responsible for nearly all cases of cervical cancer and a significant proportion of other cancers, including:
- Oropharyngeal cancer (throat/head/neck cancers)
- Anal cancer
- Penile cancer
- Vulvar and vaginal cancers
While HPV vaccination has long been recommended for girls and young women, recent studies and global health guidelines now emphasize the importance of vaccinating males to achieve broader population-level protection. The World Health Organization (WHO) estimates that HPV vaccination coverage among males remains low globally, but Singapore is making strides in closing this gap.
Singapore’s Role in Boosting Male HPV Vaccination
The Singapore Ministry of Health (MOH) has long subsidized HPV vaccines under the National Adult and Childhood Immunisation Schedule. As of 2026, the government continues to:
- Offer subsidized HPV vaccines for eligible individuals, including males aged 13–26.
- Provide same-day appointments at participating clinics nationwide.
- Run targeted public health campaigns highlighting the vaccine’s benefits for both genders.
While exact vaccination rates among males are not publicly disclosed in the most recent reports, health officials have noted a meaningful increase in demand over the past two years, particularly among young adults.
Driving Factors Behind the Rise
Several key developments are contributing to higher male HPV vaccination rates:
1. Expanded Awareness of HPV-Related Cancers in Men
Public health campaigns have increasingly emphasized that HPV is not a “female-only” issue. For example:
- Oropharyngeal cancers linked to HPV are rising globally, with men accounting for the majority of cases.
- Studies show that vaccinating males reduces HPV transmission in heterosexual couples, indirectly protecting female partners.
2. Vaccine Safety and Effectiveness
Clinical trials and real-world data confirm that HPV vaccines are:
- Highly effective at preventing HPV-related cancers when administered before exposure to the virus.
- Safe, with no credible evidence linking them to long-term adverse effects in large-scale studies.
These findings have reassured parents and young adults considering vaccination.
3. Peer and Social Influence
Word-of-mouth recommendations and social media discussions—particularly among young adults—have played a role in normalizing HPV vaccination for males. Health influencers and community leaders in Singapore have amplified messages about preventive healthcare.
Singapore’s Progress in a Global Context
Singapore’s approach aligns with global trends:
- The WHO recommends HPV vaccination for both males and females as part of comprehensive cancer prevention strategies.
- Countries like Australia and Canada have seen success with nationwide HPV vaccination programs for males, reducing HPV transmission rates.
- Singapore’s high healthcare literacy and strong public trust in government health initiatives position it well to achieve high vaccination coverage.
Frequently Asked Questions
1. Who should get the HPV vaccine in Singapore?
The Ministry of Health recommends HPV vaccination for:
- Females aged 13–26 (previously the primary focus).
- Males aged 13–26 (now increasingly encouraged).
Catch-up vaccination may be considered for individuals up to age 45, depending on clinical assessment.
2. How many doses are needed?
The standard schedule for those starting before age 15 is two doses, spaced 6–12 months apart. Those starting at or after age 15 require three doses.
3. Are there side effects?
Common side effects are mild and temporary, such as pain at the injection site, low-grade fever, or headache. Serious adverse reactions are extremely rare.
4. How can I get vaccinated?
Eligible individuals can book appointments at:
- Polyclinics under the National Healthcare Group.
- Private clinics participating in the government subsidy scheme.
Use the MOH Vaccination App or visit vaccine.gov.sg for details.
Key Takeaways
- Rising demand: More Singaporean males are seeking HPV vaccination as awareness of its cancer-preventive benefits grows.
- Government support: Subsidies and public health campaigns are accelerating uptake.
- Broader protection: Vaccinating males reduces HPV transmission and protects partners.
- Safe and effective: HPV vaccines have a strong safety profile backed by decades of research.
- Global alignment: Singapore’s approach mirrors successful programs in Australia and Canada.
What’s Next for HPV Vaccination in Singapore?
Health experts anticipate continued growth in male HPV vaccination rates, particularly if:
- More employers and insurers recognize the vaccine as a preventive health benefit.
- School-based vaccination programs expand to include males.
- Additional research highlights the vaccine’s role in reducing HPV-related cancers in men.
For now, the message is clear: HPV vaccination is no longer just a “female issue”—it’s a critical tool for cancer prevention for everyone.
Related reading